(firstQuint)Study to Compare the Efficacy and Safety of CELBESTA and CELEBREX in Patients With Rheumatoid Arthritis.

 Thisi is a multi-center, double-blind, active-controlled, randomized, parallel-group clinical trial to compare the efficacy and safety of CELBESTA(R) and CELEBREX(R) in patients with rheumatoid arthritis.

 The subject will receive two tablets twice daily for 6 weeks.

.

 Study to Compare the Efficacy and Safety of CELBESTA and CELEBREX in Patients With Rheumatoid Arthritis@highlight

This Phase IV clinical study is to Compare the Efficacy and Safety of CELBESTA(R) and CELEBREX(R) in Rheumatoid Arthritis Patients